Position in GILD
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$377,756
+$15,394 QoQ
Shares Held
2,990
+15.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#1,531
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GABLES CAPITAL MANAGEMENT INC. holds $11,549,324 across 11 Drug Manufacturers - General names. GILD ranks #7 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,805 | $3,364,401 | |
| 2 | JNJ |
Johnson & Johnson
|
12,302 | $3,124,338 | |
| 3 | MRK |
Merck & Co., Inc.
|
16,302 | $2,094,807 | |
| 4 | PFE |
Pfizer Inc
|
36,400 | $876,512 | |
| 5 | ABBV |
AbbVie Inc.
|
3,374 | $849,033 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
7,190 | $414,287 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
2,990 | $377,756 | |
| 8 | AMGN |
Amgen Inc
|
962 | $348,359 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $377,756 | 2,990 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $362,362 | 2,600 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $392,768 | 3,200 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $355,200 | 3,200 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $354,784 | 3,200 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $411,783 | 3,675 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $339,459 | 3,675 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $373,088 | 4,450 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $355,742 | 5,185 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $442,063 | 6,035 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $525,349 | 6,485 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $489,732 | 6,535 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $549,894 | 7,135 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $584,938 | 7,050 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $605,242 | 7,050 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $428,745 | 6,950 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $435,760 | 7,050 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $419,122 | 7,050 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $515,531 | 7,100 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $544,830 | 7,800 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $642,119 | 9,325 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $857,252 | 13,264 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $772,760 | 13,264 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $838,152 | 13,264 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,047,461 | 13,614 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $1,004,998 | 13,443 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||